MedPath

NABUMETONE

NABUMETONE

Approved
DIN Number

02238369

Drug Class

Human

Market Date

N/A

Company
HC

Apotex Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02238369
AIG Number0122821001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
M01AX01 NABUMETONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:08.04.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

NABUMETONEActive
Strength: 500 MG
Monograph: NABUMETONE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.